• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
NEU
Click for more information
1.06% $18.65

NEUREN PHARMACEUTICALS LIMITED

Market Cap $2.381B  ! watchlist Created with Sketch. Add to my watchlist
Healthcare

Neuren Pharmaceuticals Limited is an Australia-based biopharmaceutical company developing... Neuren Pharmaceuticals Limited is an Australia-based biopharmaceutical company developing therapies for neurodevelopmental disorders. The Company is developing new drug therapies to treat multiple serious neurological disorders that emerge in early childhood and have no or limited approved treatment options. The Company’s product DAYBUE (trofinetide) is used to treat Rett syndrome in adults and pediatric patients two years of age and older. The US Food and Drug Administration (FDA) and the European Medicines Agency (EMA) have both granted orphan drug designation to the Company for trofinetide in Fragile X syndrome. Its second product NNZ-2591 is in phase II clinical trials in Phelan-McDermid syndrome, Angelman syndrome, Pitt Hopkins syndrome and Prader-Willi syndrome. The Company has granted an exclusive worldwide license to Acadia Pharmaceuticals Inc. for the development and commercialization of trofinetide.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile arrow Created with Sketch.
See benefits

Latest Threads

Tag Subject Date Created with Sketch. Comments Created with Sketch. Views Created with Sketch.
NEU
Ann: 2023 Annual Report to shareholders
2 3
19:45 164 54K
19:45 Last post  seanc Comments Created with Sketch.  164  Views Created with Sketch.  54K 
NEU
Share Price
164 165 166
14:27 9.9K 4.4M
14:27 Last post  Hittman Comments Created with Sketch.  9.9K  Views Created with Sketch.  4.4M 
NEU
Ann: Notification of cessation of securities - NEU 		26/04/24 2 875
26/04/24 Last post  prismen Comments Created with Sketch.  2  Views Created with Sketch.  875 
NEU
Ann: Virtual AGM online guide 		26/04/24 0 432
26/04/24 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  432 
NEU
Ann: Notice of Annual General Meeting/Proxy Form 		26/04/24 0 368
26/04/24 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  368 
NEU
Acadia
6 7 8
25/04/24 422 188K
25/04/24 Last post  Piton72 Comments Created with Sketch.  422  Views Created with Sketch.  188K 
NEU
Ann: Q1 2024 quarterly activity and cash flow report 		24/04/24 15 6.2K
24/04/24 Last post  kens Comments Created with Sketch.  15  Views Created with Sketch.  6.2K 
NEU
Ann: Neuren completes enrolment in Pitt Hopkins Phase 2 trial
2
24/04/24 92 40K
24/04/24 Last post  Richo24 Comments Created with Sketch.  92  Views Created with Sketch.  40K 

See All Discussions arrow Created with Sketch.

Timeline

Notification of cessation of securities - NEU
26 Apr 16:40
 
Virtual AGM online guide
26 Apr 09:57
 
Notice of Annual General Meeting/Proxy Form
26 Apr 09:55
 
Q1 2024 quarterly activity and cash flow report
24 Apr 10:05
 
Trofinetide accepted for Priority Review by Health Canada
23 Apr 09:43
 
Appendix 4G
23 Apr 09:21
 
View More arrow Created with Sketch.

Featured News

ASM Aust Strategic sees Canada join US in possible funding push for Dubbo
right-arrow Created with Sketch.
BHP BHP confirms £31.1B takeover bid for Anglo American
right-arrow Created with Sketch.
NEWS Recharged Prospects: ‘Watts’ on the horizon for copper & lithium
right-arrow Created with Sketch.
NCK Nick Scali moves into the UK market through Fabb Furniture acquisition
right-arrow Created with Sketch.
RDN Raiden's key target areas found drill ready in cultural heritage survey
right-arrow Created with Sketch.
RCE Recce wins safety board approval to dose 4g in R327 UTI infusion trial
right-arrow Created with Sketch.

(20min delay)
Last
$18.65 		Change
-0.200(1.06%) 		Mkt cap ! $2.381B
Open High Low Value Volume
$18.85 $18.92 $18.35 $10.53M 566.6K

Buyers (Bids)

No. Vol. Price($)
1 45 $18.64
 

Sellers (Offers)

Price($) Vol. No.
$18.73 1500 1
View Market Depth
Last trade - 16.10pm 26/04/2024 (20 minute delay) ?
Last
$18.73 		  Change
-0.200 ( 0.73 %)
Open High Low Volume
$18.89 $18.89 $18.36 91292
Last updated 15.59pm 26/04/2024 ?
NEU (ASX) Chart

Top Stories

Recce Pharmaceuticals up 6% on new antibiotic production milestone

Recce Pharmaceuticals (ASX:RCE) is trading up more than 6 per cent after producing a 5000-dose batch of its new antibiotic RECCE 327 (R327) under Good Manufacturing Practises (GMP) standards.
BHP confirms £31.1B takeover bid for Anglo American BHP HAS confirmed its offer to takeover fellow mining giant Anglo American plc, following press speculation of a potential deal.which had unsettled shareholder groups and financial firms in London, and provoked criticism from a South African government minister.
Crypto world awaits overnight Bitcoin halving event The four-yearly Bitcoin halving is set to happen in the early hours of tomorrow morning (Saturday, April 20) - it's an event that industry leader Swyftx likened to 'the Olympic Games for the crypto industry'.
Lithium Universe reveals plan to fill a 'gap' in the North American market Lithium Universe has flagged its Québec Lithium Processing Hub in Canada as a key producer of battery-grade lithium to the North American market..
Regal copper grades at Gascoyne play see shares jump 33% for Augustus Augustus Minerals is reporting high grade copper rock chip results at Ti-Tree in WA based on recent fieldwork.

Featured News

NCK Nick Scali moves into the UK market through Fabb Furniture acquisition
right-arrow Created with Sketch.
RDN Raiden's key target areas found drill ready in cultural heritage survey
right-arrow Created with Sketch.
RCE Recce wins safety board approval to dose 4g in R327 UTI infusion trial
right-arrow Created with Sketch.
CC9 Chariot ends quarter charged up on lithium find in Wyoming
right-arrow Created with Sketch.
ASM Aust Strategic sees Canada join US in possible funding push for Dubbo
right-arrow Created with Sketch.
BHP BHP confirms £31.1B takeover bid for Anglo American
right-arrow Created with Sketch.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.